Philip Vickers Insider Profile
4 Followers
Philip Vickers, Director at Akebia Therapeutics, holds ― shares in Akebia Therapeutics (Ticker: AKBA), holds 29.72K shares in Revance Therapeutics (Ticker: RVNC), holds 4.80K shares in Tectonic Therapeutic (Ticker: TECX).
Philip Vickers's Trading History
You May Also Like
Philip Vickers insider profile FAQ
What is the percentage of profitable transactions made by Philip Vickers?
The percentage of profitable transactions made by Philip Vickers is 0%.
What is the average return per transaction made by Philip Vickers?
The average return per transaction made by Philip Vickers is -68.70%.
What stocks does Philip Vickers hold?
Philip Vickers holds: AKBA, RVNC, TECX stocks.
What was Philip Vickers's most profitable transaction?
Philip Vickers’s most profitable transaction was an Informative Buy of RVNC stock on March 16, 2018. The return on the trade was -50.10%.
What is Philip Vickers's role in Akebia Therapeutics?
Philip Vickers's role in Akebia Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
